Discover
CCCC
C4 Therapeutics, Inc.
4.34
2 x 3.31
2 x 5.28
bid
ask
-
0.33
7.07%
2 @ 04:24 AM
4.34 +0.00 (0.00%)
| Ytd | 127.23% | |
| 1y | 187.42% |
4.13
day range
4.73
1.43
52 week range
5.17
| Open | 4.59 | Prev Close | 4.67 | Low | 4.13 | High | 4.73 | Mkt Cap | 479.86M |
| Vol | 5.35M | Avg Vol | 3.28M | EPS | -1.10 | P/E | N/A | Forward P/E | -2.37 |
| Beta | 3.06 | Short Ratio | 7.10 | Inst. Own | 91.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.60 | 200-d Avg | 2.72 | 1yr Est | 15.00 |
CCCC News
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#
benzinga.com
C4 Therapeutics To Present Further Analysis From Fully Enrolled Phase 1 Trial Of Cemsidomide In Comb
At the 100 µg Recommended Phase 2 Dose (RP2D), Cemsidomide Demonstrated a 53% Overall Response Rate,
benzinga.com
Evercore ISI Group Maintains Outperform on C4 Therapeutics, Raises Price Target to $12
Evercore ISI Group analyst Gavin Clark-Gartner maintains C4 Therapeutics (NASDAQ:CCCC) with a Out